Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Alcohol Use Disorder
NCT02179749Phase 2Completed
- Sponsor
- Scripps Research
- Start
- Sep 2014
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Mifepristone 1200 mg with Placebo (2 arms). Primary endpoint: Drinking Quantity Per Day at 12 weeks. Started Sep 2014; status: completed.
02
Drugs
mifepristone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02179749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02179749.